The combined effects of chronic ethanol/desipramine treatment on β-adrenoceptor density and coupling efficiency in rat brain

European Journal of Pharmacology

Volumn 363, Issue 2-3, 1998, Pages 241-251

  Gurguis, George N M ^a   Turkka, Jukka ^b   Karanian, John ^c   Linnoila, Markku ^c  

^a VA NORTH TEXAS HEALTH CARE SYSTEM   (United States)

^b UNIVERSITY OF OULU   (Finland)

^c DICBR Natl Inst on Alcohol A   (United States)

Author keywords

Alcoholism; Antidepressant; Coupling; Depression; Desipramine; Ethanol; G(s) protein

Indexed keywords

ADENYLATE CYCLASE; ALCOHOL; BETA ADRENERGIC RECEPTOR; DESIPRAMINE; GUANINE NUCLEOTIDE BINDING PROTEIN; ISOPRENALINE;

ALCOHOLISM; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DEPRESSION; FRONTAL CORTEX; HIPPOCAMPUS; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; RECEPTOR DENSITY;

ADRENERGIC BETA-AGONISTS; ADRENERGIC BETA-ANTAGONISTS; ADRENERGIC UPTAKE INHIBITORS; ANIMALS; BINDING, COMPETITIVE; BRAIN; CENTRAL NERVOUS SYSTEM DEPRESSANTS; CEREBRAL CORTEX; DESIPRAMINE; DRUG INTERACTIONS; ETHANOL; HIPPOCAMPUS; IODOCYANOPINDOLOL; ISOPROTERENOL; MALE; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, ADRENERGIC, BETA;

EID: 0032545501     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0014-2999(98)00810-3     Document Type: Article

References (96)

1. Asakura M., Tsukamtot T., Kubota H., Osada K., Imafuku J., Nishizaki J., Sato A., Nakanishi J., Shimbo K., Shibata M., Hasegawa K. Involvement of protein kinase in the regulation of β-adrenergic receptors by antidepressants. Int. J. Clin. Pharmacol. Res. 9:1989;123-130.
2. Askew W.E., Charalampous K.D. Chronic ethanol and neural cAMP. Life Sci. 22:1978;639-646.
3. Banerjee S.P., Sharma V.K., Khanna J.M. Alterations in β-adrenergic receptor binding during ethanol withdrawal. Nature. 276:1978;407-409.
4. Benovic J.L., Pike L.J., Cerione R.A., Staniszewski C., Yoshimasa T., Codina J., Caron M.G., Lefkowitz R.J. Phosphorylation of the mammalian β-adrenergic receptor by cyclic AMP-dependent protein kinase: regulation of the rate of receptor phosphorylation and dephosphorylation by agonist occupancy and effects on coupling of the receptor to the stimulatory guanine nucleotide regulatory protein. J. Biol. Chem. 260:1985;7094-7101.
5. Biegon A. Effect of chronic desipramine treatment on dihydroalprenolol, imipramine, and desipramine binding sites: a quantitative autoradiographic study in the rat brain. J. Neurochem. 47:1986;77-80.
6. Bode D.C., Molinoff P.B. Effects of chronic exposure to ethanol on the physical and functional properties of the plasma membrane of S49 lymphoma cells. Biochemistry. 27:1988;5700-5707.
7. Bode D.C., Molinoff P.B. Effects of ethanol in vitro on the beta adrenergic receptor-coupled adenylate cyclase system. J. Pharmacol. Exp. Ther. 246:1988;1040-1047.
8. 1B presynaptic heteroreceptors inhibiting acetylcholine release. Neuropharmacology. 33:1994;77-81.
9. 2-adrenergic receptor: phosphorylation of the receptor and regulation of its mRNA level. J. Biol. Chem. 264:1989;16786-16792.
10. Burgisser, E., Lefkowitz, R.J., 1984. Beta adrenergic receptors. In: Marangos, P.J., Campbell, I.C., Cohen, R.M. (Eds.), Brain Receptor Methodologies, Part A. Academic Press, New York, pp. 229-253.
11. Charness M.E., Querimit L.A., Henteleff M. Ethanol differentially regulates G proteins in neural cells. Biochem. Biophys. Res. Commun. 155:1988;138-143.
12. 1B serotonin receptors. Nat. Genet. 14:1995;98-101.
13. Davies A.O., Lefkowitz R.J. Corticosteroid-induced differential regulation of β-adrenergic receptors in circulating human polymorphonuclear leukocytes and mononuclear leukocytes. J. Clin. Endocrinol. Metab. 51:1980;599-605.
14. Davies A.O., Lefkowitz R.J. Agonist promoted high affinity state of the β-adrenergic receptor in human neutrophils: modulation by corticosteroids. J. Clin. Endocrinol. Metab. 53:1981;703-707.
15. Davies A.O., DeLean A., Lefkowitz R.J. Myocardial beta-adrenergic receptors from adrenalectomized rats: impaired formation of high-affinity agonist-receptor complexes. Endocrinology. 108:1981;720-722.
16. DeLean A., Stadel J.M., Lefkowitz R.J. A ternary complex model explains the agonist-specific binding properties of the adenylate cyclase-coupled β-adrenergic receptor. J. Biol. Chem. 255:1980;7108-7117.
17. DeLean A., Hancock A.A., Lefkowitz R.J. Validation and statistical analysis of a computer modeling method for quantitative analysis of radioligand binding data for mixtures of pharmacological receptor subtypes. Mol. Pharmacol. 21:1982;5-16.
18. 3H ]desipramine binding sites J. Pharmacol. Exp. Ther. 248:1989;470-477.
19. Edwards E., Whitaker-Azmitia P.M. Selective β-antagonists are equally and highly potent at 5-HT sites in the rat hippocampus. Neuropharmacology. 26:1987;93-96.
20. 2 and β-adrenergic receptor regulation in rat brain following chronic treatment with desipramine and fluoxetine alone and in combination. J. Neurochem., pp. 2262-2268.
21. 125[I] -iodocyanopindolol binding parameters to beta-adrenergic receptors in rat brain Eur. Neuropsychopharmacol. 8:1998;131-140.
22. Hancock A.A., Marsh C.L. Agonist interactions with beta-adrenergic receptors following chronic administration of desipramine or the atypical antidepressants, iprindole and mianserin. J. Recept. Res. 5:1985;311-334.
23. Hatta S., Saito T., Ohshika H. Effects of ethanol on the function of G proteins in rat cerebral cortex membranes. Alcohol Alcohol. 29(Suppl. 1):1994;45-51.
24. 2-adrenergic receptor are involved in distinct pathways of receptor desensitization. J. Biol. Chem. 264:1989;12657-12665.
25. Hoffman, P.L., Valverius, P., Kwast, M., Tabakoff, B., 1987. Comparison of the effects of ethanol on beta-adrenergic receptors in heart and brain. Alcohol Alcohol. (Suppl. 1), pp. 749-754.
26. Honegger U.E., Disler B., Wiesmann U.N. Chronic exposure of human cells in culture to the tricyclic antidepressant desipramine reduces the number of beta-adrenoceptors. Biochem. Pharmacol. 35:1986;1899-1902.
27. Hosoda K., Duman R.S. Regulation of beta 1-adrenergic receptor mRNA and ligand binding by antidepressant treatments and norepinephrine depletion in rat frontal cortex. J. Neurochem. 60:1993;1335-1343.
28. 125I ]iodocyanopindolol Eur. J. Pharmacol. 118:1985;1-12.
29. 3H ]ketanserin Eur. J. Pharmacol. 118:1985;13-23.
30. Hunt W.A., Dalton T.K. Neurotransmitter-receptor binding in various brain regions in ethanol-dependent rats. Pharmacol. Biochem. Behav. 14:1991;733-739.
31. s-protein in rat liver plasma membranes. Hepatology. 21:1995;1154-1160.
32. 1B receptor being a 5-HT autoreceptor. Pharmacol. Toxicol. 70:1992;131-134.
33. Karanian J., Yergey J., Lister R., D'Souza N., Linnoila M., Salem N. Characterization of an automated apparatus for precise control or inhalation chamber ethanol vapor and blood ethanol concentrations. Alcohol Clin. Exp. Res. 10:1986;443.
34. Kent R.S., DeLean A., Lefkowitz R.J. A quantitative analysis of beta-adrenergic receptor interactions: resolution of high and low affinity states of the receptor by computer modeling of ligand binding data. Mol. Pharmacol. 17:1980;14-23.
35. Kuriyama K. Ethanol-induced changes in activities of adenylate cyclase, guanylate cyclase and cyclic adenosine 3,5-monophosphate dependent protein kinase in the brain and liver. Drug Alcohol Depend. 2:1977;335-348.
36. Kuriyama, K., Israel, M.A., 1973. Effect of chronic ethanol administration on adenyl cyclase and cyclic 3,5-nucleotide phosphodiesterase activities of mouse brain. In: Lissak, K. (Ed.), Hormones and Brain Function. Budapest, pp. 293-296.
37. Kuriyama K., Muramatsu M., Aiso M., Ueno E. Alteration in β-adrenergic receptor binding in brain, lung and heart during morphine and alcohol dependence and withdrawal. Neuropharmacology. 20:1981;659-666.
38. Lason W., Przewlocki R. The effect of chronic treatment with imipramine on the G proteins mRNA level in the rat hippocampus - an interaction with a calcium channel antagonist. Pol. J. Pharmacol. 45:1993;219-226.
39. o subunits. Eur. J. Pharmacol. 207:1991;361-364.
40. Light K.E., Stull R.E. Time course of altered brain neurotransmitter receptor binding parameters in rats chronically treated with ethanol. Proc. West. Pharmacol. Soc. 25:1982;253-256.
41. Lowry O.H., Rosebrough N.J., Farr A.L., Randall R.J. Protein measurement with folin phenol reagent. J. Biol. Chem. 193:1951;265-275.
42. Manier D.H., Gillespie D.D., Sulser F. Dual aminergic regulation of central beta adrenoceptors. Neuropsychopharmacology. 2:1989;89-95.
43. H ratio. Eur. J. Pharmacol. 206:1991;159-162.
44. 2. Psychopharmacol. Bull. 27:1991;247-253.
45. McBride, W.J., Murphy, J.M., Gatto, G.J., Levy, A.D., Yoshimoto, K., Lumeng, L., Li, T.-K., 1993. CNS mechanisms of alcohol self-administration. Alcohol Alcohol. (Suppl. 2), pp. 463-467.
46. McBride W.J., Chernet E., Russell R.N., Wong D.T., Guan X.-M., Lumeng L., Li T.-K. Regional CNS densities of monoamine receptors in alcohol-naive alcohol-preferring P and -nonpreferring NP rats. Alcohol. 14:1997;141-148.
47. Middlemiss D.N. Blockade of the central 5-HT autoreceptor by β-adrenoceptor antagonist. Eur. J. Pharmacol. 120:1986;51-56.
48. 3 sites in rat brain. Jpn. J. Pharmacol. 47:1988;107-113.
49. Mochly-Rosen D., Chang F.-H., Cheever L., Kim M., Diamond I., Gordon A.S. Chronic ethanol causes heterologous desensitization of receptors by reducing messenger RNA. Nature. 333:1988;848-850.
50. 1B receptors in rat brain Eur. J. Pharmacol. 196:1991;327-329.
51. Munson P.J., Rodbard D. LIGAND: a versatile computerized approach for characterization of ligand binding systems. Anal. Biochem. 197:1983;220-239.
52. s) in human erythrocyte membranes in relation to alcohol consumption. Clinica Chimica Acta. 218:1993;229-231.
53. Nelson D.R., Pratt G.D., Palmer K.J., Johnson A.M., Bowery N.G. Effect of paroxetine, a selective 5-hydroxytryptamine uptake inhibitor, on -adrenoceptors in rat brain: autoradiographic and functional studies. Neuropharmacology. 30:1991;607-616.
54. 1B receptor subtypes in rat brain. Eur. J. Pharmacol. 281:1995;229-239.
55. Nhamburo P.T., Hoffman P.L., Tabakoff B. Cholera toxin-induced ADP-ribosylation of a 46 kDa protein is decreased in brains of ethanol-fed mice. Adv. Alcohol Subst. Abuse. 7:1988;103-105.
56. 3H ]forskolin binding to rat cerebral cortical membranes Jpn. J. Psychiatry Neurol. 45:1991;125-126.
57. Okada F., Tokumitsu Y., Ui M. Desensitization of beta-adrenergic receptor-coupled adenylate cyclase in cerebral cortex after in vivo treatment of rats with desipramine. J. Neurochem. 47:1986;454-459.
58. o) in desipramine-induced refractoriness of adenylate cyclase in cerebral cortices of rats. J. Neurochem. 51:1988;194-199.
59. Ordway G.A., Gambarana C., Frazer A. Quantitative autoradiography of central beta adrenoceptor subtypes: comparison of the effects of chronic treatment with desipramine or centrally administered I-isoproterenol. J. Pharmacol. Exp. Ther. 247:1988;379-389.
60. 125I -iodopindolol to beta-1 adrenoceptors in the amygdala of rat after antidepressant treatments J. Pharmacol. Exp. Ther. 257:1991;681-690.
61. Ozawa H., Katamura Y., Hatta S., Saito T., Katada T., Gsell W., Froelich L., Takahata N., Riederer P. Alterations of guanine nucleotide-binding proteins in post-mortem human brain in alcoholics. Brain Res. 620:1993;174-179.
62. Ozawa H., Katamura Y., Hatta S., Amemiya N., Saito T., Ohshika H., Takahata N. Antidepressants directly influence in situ binding of guanine nucleotide in synaptic membrane. Life Sci. 54:1994;925-932.
63. i/o in the cerebral cortex of alcoholic patients. Alcohol Alcohol. 29:1994;93-97.
64. Paetsch P.R., Greenshaw A.J. Effects of chronic antidepressant treatment on -adrenoceptor subtype binding in the rat cerebral cortex and cerebellum. Mol. Chem. Neuropathol. 20:1993;21-31.
65. 1B) receptor subtypes in the brain of ethanol-treated rats. Drug Alcohol Depend. 41:1996;219-225.
66. 2 receptors after antidepressant administration in the forced swim test and after chronic antidepressant drug treatment. J. Pharmacol. Exp. Ther. 246:1988;956-962.
67. Pilc, A., Vetulani, J., Enna, S.J., 1990. Antidepressant effects on adrenoceptor interactions in brain. In: Leonard, B., Spencer, P. (Eds.), Antidepressants: Thirty Years On. CNS Publishers, London, pp. 36-45.
68. Rabin R.A. Ethanol-induced desensitization of adenylate cyclase: role of the adenosine receptor and GTP-binding proteins. J. Pharmacol. Exp. Ther. 264:1993;977-983.
69. Rabin R.A., Edelman A.M., Wagner J.A. Activation of protein kinase A is necessary but not sufficient for ethanol-induced desensitization of cyclic AMP production. J. Pharmacol. Exp. Ther. 262:1992;257-262.
70. Richardson J.S., Hertz L. The effects of antidepressant drugs on adenylyl cyclase linked beta adrenergic binding sites on mouse astrocytes in primary cultures. Prog. Neuropsychopharmacol. Biol. Psychiatry. 7:1983;675-680.
71. 1B receptors. Alcohol Clin. Exp. Res. 20:1996;1401-1405.
72. Rommelspacher, H., Strauss, S., 1987. Down-regulation of cerebral -adrenoceptors induced by long term administration of antidepressants is prevented by ethanol. Alcohol Alcohol. (Suppl. 1), pp. 697-701.
73. Saffey K., Gillman M.A., Cantrill R.C. Chronic in vivo ethanol administration alters the sensitivity of adenylate cyclase coupling in homogenates of rat brain. Neurosci. Lett. 84:1988;317-322.
74. Saito T., Lee J.M., Hoffman P.L., Tabakoff B. Effects of chronic ethanol treatment on the β-adrenergic receptor-coupled adenylate cyclase system of mouse cerebral cortex. J. Neurochem. 48:1987;1817-1822.
75. Schwaninger M., Schöfl C., Blume R., Rössig L., Knepel W. Inhibition by antidepressant drugs of cyclic AMP response element-binding protein/cyclic AMP response element-directed gene transcription. Mol. Pharmacol. 47:1995;1112-1118.
76. Sethy V.H., Day J.S., Cooper M.M. Dose-dependent down-regulation of beta-adrenergic receptors after chronic intravenous infusion of antidepressants. Prog. Neuropsychopharmacol. Biol. Psychiatry. 12:1988;673-682.
77. Sibley D.R., Strasser R.H., Caron M.G., Lefkowitz R.J. Homologous desensitization of adenylate cyclase is associated with phosphorylation of the β-adrenergic receptor. J. Biol. Chem. 260:1985;3883-3886.
78. Sleight A.J., Smith R.J., Marsden C.A., Palfreyman M.G. The effects of chronic treatment with amitriptyline and MDL72394 on the control of 5-HT release in vivo. Neuropharmacology. 28:1989;477-480.
79. Strasser R.H., Lefkowitz R.J. Homologous desensitization of β-adrenergic receptor coupled adenylate cyclase. J. Biol. Chem. 260:1985;4561-4564.
80. Sulser, F., 1990. Mode of action of antidepressants: from traditional biochemical to molecular neuropsychopharmacology. In: Leonard, B., Spencer, P. (Eds.), Antidepressants: Thirty Years On. CNS Publishers, London, pp. 23-35.
81. Sulser F., Vetulani J., Mobley P.L. Mode of action of antidepressant drugs. Biochem. Pharmacol. 27:1978;257-261.
82. Sulser F., Gillespie D.D., Mishra R., Manier D.H. Desensitization by antidepressants of central norepinephrine receptor systems coupled to adenylate cyclase. Ann. NY Acad. Sci. 430:1984;91-101.
83. Tabakoff B., Whelan J.P., Ovchinnikova L., Nhamburo P., Yoshimura M., Hoffman P.L. Quantitative changes in G proteins do not mediate ethanol-induced downregulation of adenylyl cyclase in mouse cerebral cortex. Alcohol Clin. Exp. Res. 19:1995;187-194.
84. Thurman R.G., Harden T.K., Winn K. Cyclic AMP and β-adrenergic receptors during the development of physical dependence on ethanol in the rat. Adv. Exp. Med. Biol. 126:1980;145-155.
85. Tsuchiya F., Ikeda H., Hatta Y., Saito T. Effects of desipramine administration on receptor adenylate cyclase coupling in rat cerebral cortex. Jpn. J. Psychiatry Neurol. 42:1988;858-859.
86. H for β-receptors in rat hippocampus. Eur. J. Pharmacol. 167:1989;87-93.
87. Turkka J., Gurguis G.N.M., Karanian J., Potter W.Z., Linnoila M. Effects of chronic exposure to ethanol alone and in combination with desipramine on the properties of beta-adrenoreceptors of rat frontal cortex and hippocampal membranes. Eur. J. Pharmacol. 177:1990;171-179.
88. Valverius P., Hoffman P.L., Tabakoff B. Effect of ethanol on mouse cerebral cortical β-adrenergic receptors. Mol. Pharmacol. 32:1987;217-222.
89. Valverius P., Hoffman P.L., Tabakoff B. Effects of chronic ethanol ingestion on mouse brain β-adrenergic receptors (AR) and adenylate cyclase. Adv. Alcohol. Subst. Abuse. 7:1988;99-101.
90. Valverius P., Borg S., Valverius M.R., Hoffman P.L., Tabakoff B. Adrenergic receptor binding in brain of alcoholics. Exp. Neurol. 105:1989;280-286.
91. Valverius P., Hoffman P.L., Tabakoff B. Hippocampal and cerebellar β-adrenergic receptors and adenylate cyclase are differentially altered by chronic ethanol ingestion. J. Neurochem. 52:1989;492-497.
92. Vetulani J., Stawarz R.J., Dingell J.V., Sulser F. A possible common mechanism of action of antidepressant treatments. Naunyn-Schmiedeberg's Arch. Pharmacol. 293:1976;109-114.
93. s, and adenylyl cyclase activity in ethanol-treated LS mice. Alcohol Clin. Exp. Res. 15:1991;705-710.
94. Wang Y., Jeng C.-H., Lin J.-C., Wang J.-Y. Serotonin modulates ethanol-induced depression in cerebellar purkinje neurons. Alcohol Clin. Exp. Res. 20:1996;1229-1236.
95. Williams R.J., Veale M.A., Horne P., Kelly E. Ethanol differentially regulates guanine nucleotide-binding protein subunit expression in NG108-15 cells independently of extracellular adenosine. Mol. Pharmacol. 43:1993;158-166.
96. Yamamoto H., Kagaya A., Kuroda Y., Mikuni M., Takahashi K. Effect of antidepressants on the GTP binding sites in rat brain homogenate. Jpn. J. Psychiatry Neurol. 44:1990;133-134.